EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease

Hannah Whittaker, Constantinos Kallis, Thomas Bolton, Angela Wood iD, Samantha Walker, Aziz Sheikh, Alex Brownrigg, Ashley Akbari iD, Kamil Sterniczuk, Jennifer K Quint, CVD-COVID-UK/COVID-IMPACT Consortium

International Journal of Epidemiology · 2024

DOI: 10.1093/ije/dyae068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Epidemiology, 2024. Verfasst von Hannah Whittaker und 10 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory EHR, School of Public Health, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Asthma, Cardiovascular Diseases, COVID-19, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, British Heart Foundation Data Science Centre, Health Data Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COVID-19 is associated with cardiovascular outcomes in the general population, but it is unknown whether people with chronic respiratory disease (CRD) have a higher risk of cardiovascular events post-COVID-19 compared with the general population and, if so, what respiratory-related factors may modify this risk in these people.

Methods

Primary and secondary care data from the National Health Service England were used to define a population of adults in England with COVID-19 (index date) between 1 January 2020 and 30 November 2021. Adjusted Cox proportional hazard regression was used to quantify the association between CRD, asthma-related factors, chronic obstructive pulmonary disease (COPD)-related factors, and risk of cardiovascular events. Asthma-specific factors included baseline asthma control, exacerbations, and inhaled corticosteroid (ICS) dose. COPD-specific risk factors included baseline ICS and exacerbations. Secondary objectives quantified the impact of COVID-19 hospitalisation and vaccine dose on cardiovascular outcomes.

Results

Of 3 670 455 people, those with CRD had a higher risk of cardiovascular events [adjusted hazard ratio (HRadj), 1.08; 95% confidence interval (CI) 1.06–1.11], heart failure (HRadj, 1.17; 95% CI, 1.12–1.22), angina (HRadj, 1.13; 95% CI, 1.06–1.20) and pulmonary emboli (HRadj, 1.24; 95% CI, 1.15–1.33) compared with people without CRD. In people with asthma or COPD, baseline exacerbations were associated with a higher risk of cardiovascular outcomes (HRadj, 1.36; 95% CI, 1.27–1.00 and HRadj, 1.35; 95% CI, 1.24–1.46, respectively). Regardless of CRD, the risk of cardiovascular events was lower with increasing COVID-19 vaccine dose.

Conclusions

Higher risk of cardiovascular events post-COVID-19 might be explained by the underlying severity of the CRD, and COVID-19 vaccines were beneficial to both people with and those without CRD with regards to cardiovascualr events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaCardiovascular DiseasesCOVID-19Pulmonary Disease, Chronic ObstructiveAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedChronic DiseaseCOVID-19 VaccinesEnglandHospitalizationProportional Hazards ModelsRisk Factors

Stichwörter der Autor:innen

COPDCOVID-19asthmacardiovascular disease

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Respiratory EHR, School of Public Health, Imperial College London, London, UK.
  • British Heart Foundation Data Science Centre, Health Data Research UK, London, UK.
  • Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Asthma + Lung, London, UK.
  • British Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, UK.
  • Usher Institute, University of Edinburgh, Edinburgh, UK.

ORCID-Profile: Angela Wood, Ashley Akbari

Förderung

  • Medical Research Council
  • British Heart Foundation Data Science Centre
  • Health Data Research
  • UK Research and Innovation

Zitieren

APA

Whittaker, H., Kallis, C., Bolton, T., Wood, A., Walker, S., Sheikh, A., Brownrigg, A., Akbari, A., Sterniczuk, K., Quint, J. K., & CVD-COVID-UK/COVID-IMPACT Consortium (2024). Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyae068

Vancouver

Whittaker H, Kallis C, Bolton T, Wood A, Walker S, Sheikh A, et al. Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease. International Journal of Epidemiology. 2024. doi:10.1093/ije/dyae068

BibTeX
@article{Whittaker2024,
  author = {Whittaker, Hannah and Kallis, Constantinos and Bolton, Thomas and Wood, Angela and Walker, Samantha and Sheikh, Aziz and Brownrigg, Alex and Akbari, Ashley and Sterniczuk, Kamil and Quint, Jennifer K and CVD-COVID-UK/COVID-IMPACT Consortium, CVD-COVID-UK/COVID-IMPACT Consortium},
  title = {Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease},
  journal = {International Journal of Epidemiology},
  year = {2024},
  doi = {10.1093/ije/dyae068}
}
Kostenlos starten →